Bandingkan Harga & Kinerja Waran Seri I Kokoh Exa Nusantara Tbk. (KOCI-W) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Waran Seri I Kokoh Exa Nusantara Tbk. dan Tempo Scan Pacific Tbk.: Waran Seri I Kokoh Exa Nusantara Tbk. diperdagangkan di Rp7 (kapitalisasi pasar 2,39 M, volume 24 jam 5,18 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.780 (kapitalisasi pasar 12,58 T, volume 24 jam 235,2 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 5263,6× kapitalisasi pasar Waran Seri I Kokoh Exa Nusantara Tbk., dan Waran Seri I Kokoh Exa Nusantara Tbk. lebih aktif diperdagangkan (5,18 jt vs 235,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| KOCI-W | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 2,39 M | 12,58 T |
Volume | 5,18 jt | 235,2 rb |
Lot | 51,82 rb | 2,35 rb |
Perputaran | 31,33 jt | 649,94 jt |
Harga Rata-rata | 6,05 | 2.763,37 |
Nilai Transaksi | 31,33 jt | 649,94 jt |
Harga Ekuilibrium Indikatif | 7 | 2.780 |
Volume Ekuilibrium Indikatif | 1 | 9 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Waran Seri I Kokoh Exa Nusantara Tbk.
PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Selengkapnya di halaman KOCI-W →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
